Formulation screen

Pharmaterials have 96 well plate reading Raman microscopy and transmission powder X-ray diffraction with robotic dispensing.

This allows a range of experiments to be carried out using the 96 well plate format.

The benefits are speed and low material need.

The 96 well plate solubility screen

This format allows co-solvent and lipid based formulation components to be studied to assess the solubility of an API

The 96 well plate amorphous dispersion screen

This format allows polymer and excipient (e.g surfactant) combinations to be tested to assess the ability to make amorphous dispersions, the relative extents of dissolution in buffer and the stability of the dispersions on accelerated storage – all using mg quantities of api per well.

Our early phase formulation screen is the first stage addition to the developability screen and sets you on the route to pre-clinical and clinical formulation with the information you need for successful rapid development.

Pharmaterials: state-of-the-art instruments, combining screening of physical form with formulation development.

We don’t just measure we understand.